Unlike the self-limiting fibrosis observed in BLM-induced models post-treatment cessation, TGF-β1-overexpressing systems demonstrate progressive fibrotic deterioration that better mirrors the relentless disease progression observed in human IPF. Here, TGFB1 is linked to idiopathic pulmonary fibrosis.